Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/4/2024
Rohto and Mitsui to Buy TCM Company for $590M
4/1/2024
CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...
2/5/2024
CMS Licenses Greater China Rights of First-line Phosphate-lowering Dru...
1/23/2024
Chinese TCM Institutions Provided Diagnosis and Treatment to 1.28B Peo...
10/30/2023
CDE Solicits Comments on the Technical Guidelines for Stability Study ...
10/24/2023
CDE Solicits Comments on the Technical Guidelines for Clinical R&D of ...
10/18/2023
CDE Issues the Technical Guidelines for Pharmaceutical Research of New...
8/24/2023
CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
3/30/2023
Rxilient and Junshi form JV to Develop and Commercialize Toripalimab i...
2/14/2023
NMPA Issues the Special Rules for TCM Registration
12/22/2022
CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs
12/5/2022
Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...
11/11/2022
NMPA Solicits Comments on the Special Rules for TCM Registration
9/27/2022
CDE Solicits Comments on Two Draft Guidelines on TCM Registration
5/10/2022
NMPA Issues Two Guidelines for TCM Registration and Evaluation
3/11/2022
CDE Solicits Comments on Two Draft TCM Registration Guidelines
1/7/2022
CDE Issues the Technical Guidance for Research of New TCM Toxicology S...
9/22/2021
China-based CMS Joins BaseLaunch as Latest Partner
3/25/2021
Shanghai Passes Law to Facilitate Traditional Chinese Medicine
3/12/2021
CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes
2/5/2021
CMS Acquires Dermatology Specialty Firm Luqa
1/15/2021
CDE Issues the Technical Guidelines for Quality Studies of TCM New Dru...
12/17/2020
CDE Issues the Technical Guidelines for Biological Effect Detection St...
11/10/2020
CDE Issues the Pharmaceutical Dossiers Requirements for Communication ...
10/22/2020
CDE Issues the Guidance for Acceptance and Evaluation of TCMs
9/28/2020
NMPA Issues the Registration Classification and Dossier Requirements o...
8/21/2020
Sun Pharma and CMS Enter into License Deal for Tildrakizumab in Greate...
6/4/2020
Beijing Plans to Criminalize Criticisms of Traditional Chinese Medicin...
4/30/2020
NMPA Solicits Comments on Six Draft TCM Registration Rules
1/20/2020
Zydus and CMS enter into a License Agreement for Desidustat in Greater...
Page:
1
/
4
Total number of articles:
102
:
[First]
[<<]
[1]
[2]
[3]
[4]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit